T. Rowe Price Associates
CADX

T. Rowe Price Associates’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

T. Rowe Price Associates’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-5,975,818
Closed -$54.1M – 2546
2013
Q4 		$54.1M Sell
5,975,818
-1,239,000
-17% -$11.2M 0.01% 811
2013
Q3 		$45.5M Sell
7,214,818
-170,323
-2% -$1.07M 0.01% 846
2013
Q2 		$50.4M Buy
+7,385,141
New +$50.4M 0.01% 779